Navigation Links
China Medicine Announces Strong Third Quarter 2009 Results
Date:11/16/2009

GUANGZHOU, China, Nov. 16 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a developer and a leading distributor of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines (TCM), nutritional and dietary supplements, and medical devices and medical formulations, today announced its third quarter 2009 results.

    Third Quarter 2009 Highlights:
    -- Revenues increased 82.2% from Q3 of 2008 to $19.2 million
    -- Gross profit increased 78.9% from Q3 of 2008 to $5.8 million
    -- Operating income increased 94.7% from Q3 of 2008 to $4.5 million
    -- Adjusted net income, which excluded a non-cash expense related to
       change in fair value of warrants for the third quarter of 2009, was
       $3.4 million, or $0.22 per diluted share
    -- Net income was $3.2 million, or $0.21 per diluted share
    -- Entered into a two-year Distribution and Supply Agreement in Pakistan
       for Levocarnitine
    -- Entered into agreement to acquire LifeTech Pharmaceuticals, Co. Ltd., a
       developer, manufacturer and marketer of pharmaceutical products with a
       portfolio of 39 TCM and Western medicine products

"We are delighted to report that China Medicine experienced a strong third quarter in 2009 with significant increases in revenues and net income. As the government implements its plan to support rural healthcare and establish a universal healthcare system, we expect to be positively impacted as we distribute pharmaceutical products through our extensive distribution network that addresses this underserved market. In addition, once the recent acquisition of LifeTech is consummated, we should be positioned as a stronger player in the pharmaceutical industry as we will have the ability to sell LifeTech's self-manufactured pharmaceutical products through our extensive distribution network, thus improving our margin structure," sa
'/>"/>

SOURCE China Medicine Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Chindex International Announces Participation in Brean Murray, Carret & Co. 2009 China Growth Conference
2. China National Medicines Corporation Issues Milestone Purchase Order for 12,000 STA Systems
3. China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou
4. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
5. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
6. China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance
7. Varian Medical Systems to Exhibit a Wide Selection of Flat Panel X-Ray Image Detectors and X-Ray Tubes at the CMEF Show in Chengdu, China
8. China Medical Technologies to Hold its Annual General Meeting on November 16, 2009
9. Reportlinker Adds Outsourcing Preclinical Studies to China
10. Baxa Corporation Signs Exclusive Distribution Agreement With Leading Pharmaceutical Corporation in Peoples Republic of China
11. China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , Sept. 4, 2015 Physician E-sampling is ... and has become a key marketing sales tactic in ... fully adopt E-sampling as a supplement to traditional sampling. ... Best Practices, LLC, physician E-sampling has been seeded across ... chronic areas. While E-sampling has been in place for ...
(Date:9/4/2015)... -- Janssen Research & Development, LLC (Janssen) announced today ... accepted for Priority Review the Biologics License Application ... with multiple myeloma who are refractory to both ... (IMiD), or who have received three or more ... an IMiD. This is referred to as "double ...
(Date:9/4/2015)... Fair Rate Funding, a lawsuit funding firm located in ... in lawsuit filings in connection with the blood thinning drug, ... Philadelphia Court of Common Pleas has risen ... Louisiana multi---district litigation (MDL), located in the ... Louisiana , the filings are also on the rise, ...
Breaking Medicine Technology:Current and Future Trends in Physician E-Sampling Programs for the Pharmaceutical Industry 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 3U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 4U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 5U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 6U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 7Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 2Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 3
... April 9, 2008 Dutch biotechnology,company Crucell N.V., ... South,African Tuberculosis Vaccine Initiative (SATVI) present a progress ... tuberculosis vaccine study at the,biennial "Tuberculosis Vaccines for ... today. The study, conducted in Worcester, South,Africa and ...
... NEW YORK, April 9, 2008 Intra-Cellular ... its ongoing development,programs for ITI-007, the Company,s ... (DPPM), and ITI-722,a low-dose formulation of ITI-007, ... disorders, respectively. These new data demonstrate,ITI-007 has ...
Cached Medicine Technology:Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 2Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 3Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 5Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 6Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722 2Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722 3
(Date:9/5/2015)... ... ... a cyber nightmare come to life in the privacy of one’s own home can be ... back helplessly as a hacker took control over their digital world, as reported this ... the whole situation that much more jarring to the senses for the family, they should ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... According to ... elderly Americans currently being cared for in nursing homes and assisted living facilities are ... discussed a personal story in which her father was at one point close to ...
(Date:9/4/2015)... ... September 04, 2015 , ... On the heels ... doubled the size of its annual health tech innovation program. Now featuring a ... startups to compete for cash and prizes to advance their technologies toward commercialization, ...
(Date:9/4/2015)... ... September 04, 2015 , ... The Schmidt National Law Group filed ... Paz. , Schmidt National Law Group, a leading firm in mass-tort litigation, has ... Bayer Corp., Bayer Essure, Inc., and other Bayer affiliates for injuries alleged to have ...
(Date:9/4/2015)... ... September 04, 2015 , ... Georgia Insurance Advisors, a locally ... effort to provide for the family of Grace, a young local girl battling ... often leads to diastolic dysfunction – the inability to adequately move blood through ...
Breaking Medicine News(10 mins):Health News:IT Security Beware: A Cyber Security Nightmare at Work Can Start at Home 2Health News:IT Security Beware: A Cyber Security Nightmare at Work Can Start at Home 3Health News:IT Security Beware: A Cyber Security Nightmare at Work Can Start at Home 4Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 2Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 3Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3
... Unique Intelligent Order Routing allows hospital pharmacies to design ... levels , , ROSEMONT, Ill., June 15 ... Omnicell, Inc., (Nasdaq: OMCL ) a leading ... announced the Omnicell WorkflowRx (TM) 6.0 ...
... In honor of ... issues , ... June 15, 2009 -- In recognition of National Men,s Health Week, June 15-21, 2009, and ... to share their health-related experiences online and increase the dialogue around preventive care and common ...
... Early results from the second series of trials have ... a 4.4 log reduction (99.994%) in Methicillin Resistant Staph Aureus ... medical treatment facilities world wide with the spread of MRSA ... CDC reported (JAMA 2007) that MRSA alone is now associated ...
... RIVER, N.J., June 15 PDI, Inc. (Nasdaq: ... to U.S. pharmaceutical companies, announces new business wins with four ... expected to contribute approximately $9 million in combined revenue in ... nearly $10 million in revenue in 2010. , , ...
... DELRAY BEACH, Fla., June 15 Anyone considering hair ... procedure. , , Just the fact that it is ... Dangerous?" "This is one of the most common questions that ... Shiell, Founder of The Oro Organization, LLC. Shiell explains, "People ...
... Mass., June 15 Joseph F. Finn, Jr., C.P.A. ("Finn") announced ... and blocks the effects of galectin-3. Galectin-3 plays an important ... and tumor metastasis, which is the spread of cancer beyond its ... multiple benefits in combating cancer cells, including: , , , ...
Cached Medicine News:Health News:Omnicell Boosts Pharmacy Efficiency with Enhanced WorkflowRx(TM) Central Pharmacy Automation Software 2Health News:Omnicell Boosts Pharmacy Efficiency with Enhanced WorkflowRx(TM) Central Pharmacy Automation Software 3Health News:Tough Guys Speak Out About Men's Health On The Healthcare Scoop 2Health News:Tough Guys Speak Out About Men's Health On The Healthcare Scoop 3Health News:Medizone Announces That Its AsepticSure(TM) Development Program is Reaching Objectives on Two Fronts 2Health News:PDI, Inc. Announces New Business Wins Exceeding $18 Million 2Health News:PDI, Inc. Announces New Business Wins Exceeding $18 Million 3Health News:USHairReplacement.com Provides Wealth of Knowledge to Common Hair Replacement Questions 2Health News:Prospect Therapeutics' In Vitro Studies Demonstrate that GCS-100 Drug Binds to and Blocks the Effects of Galectin-3 2
... The Alaris System integrates drug ... practice guidelines,into a single, modular platform. ... or remove modules as you,need them, ... the bedside,to a minimum while managing ...
... Eraser instruments have been designed to ... right tool for situations requiring precise ... of 25 gauge intraocular, bipolar, diathermy ... of target tissues for fine-tip hemostasis ...
... first steps any hospital or health system ... powerful, most effective tools available for physicians ... clinician documentation and electronic medical record (EMR) ... this goal. In fact, its the most ...
... Eraser instruments have been designed to ... right tool for situations requiring precise ... of 25 gauge intraocular, bipolar, diathermy ... of target tissues for fine-tip hemostasis ...
Medicine Products: